Taranto AG

References (3)

Title : Development of Potential Multi-Target Inhibitors for Human Cholinesterases and Beta-Secretase 1: A Computational Approach - Barbosa_2023_Pharmaceuticals.(Basel)_16_
Author(s) : Barbosa DB , do Bomfim MR , de Oliveira TA , da Silva AM , Taranto AG , Cruz JN , de Carvalho PB , Campos JM , Santos CBR , Leite FHA
Ref : Pharmaceuticals (Basel) , 16 : , 2023
Abstract :
PubMedSearch : Barbosa_2023_Pharmaceuticals.(Basel)_16_
PubMedID: 38139784

Title : Identification of Potential Multitarget Compounds against Alzheimer's Disease through Pharmacophore-Based Virtual Screening - Mendes_2023_Pharmaceuticals.(Basel)_16_1645
Author(s) : Mendes GO , Araujo Neto MF , Barbosa DB , Bomfim MRD , Andrade LSM , Carvalho PB , Oliveira TA , Falkoski DL , Maia EHB , Valle MS , Damazio LCM , Silva AMD , Taranto AG , Leite FHA
Ref : Pharmaceuticals (Basel) , 16 :1645 , 2023
Abstract :
PubMedSearch : Mendes_2023_Pharmaceuticals.(Basel)_16_1645
PubMedID: 38139772

Title : Molecular Multi-Target Approach for Human Acetylcholinesterase, Butyrylcholinesterase and beta-Secretase 1: Next Generation for Alzheimer's Disease Treatment - Mendes_2023_Pharmaceuticals.(Basel)_16_880
Author(s) : Mendes GO , Pita S , Carvalho PB , Silva MPD , Taranto AG , Leite FHA
Ref : Pharmaceuticals (Basel) , 16 :880 , 2023
Abstract :
PubMedSearch : Mendes_2023_Pharmaceuticals.(Basel)_16_880
PubMedID: 37375827